Search Results
Mar 16, 2026, 09:00 ET Understood Care Raises $8.4M to Scale AI-Native Infrastructure Layer for Patient Advocacy
tackling a massive, underserved market with an AI-native solution that genuinely improves people's lives during their most vulnerable moments. It's rare to find an investment opportunity that combines exceptional talent, enormous commercial potential, and meaningful social impact.""Understood
More news about: Understood Care
Mar 16, 2026, 09:00 ET Enchant Your Cup with Harry Potter® and Coffee mate® at The Butterbeer Cafe in NYC
baristas will craft the perfect brew just for you:Coffee mate® Frosted Phoenix: This iced coffee slushie is rare, but powerful with flavor in every sip. It features rich Butterbeer Flavored Creamer and Cold Foam with a touch of fiery red sugar.Coffee
More news about: Coffee mate®
Mar 16, 2026, 08:45 ET We Walk This Road Alone
condition, yet one that is often misunderstood or viewed solely in a negative light. In an increasingly interconnected world, time spent alone can seem rare or even undesirable. Yet psychological research suggests the opposite: periods of solitude are essential to personal development, creating space for
More news about: Rehs Contemporary Galleries, Inc.
Mar 16, 2026, 08:15 ET Ramaco Resources Announces First Quarter Class B Stock Dividend Details
mining complexes in Central Appalachia and one coal mine and rare earth development near Sheridan, Wyoming (the "Brook Mine") in the initial stages of production.In 2023, the Company announced that a major deposit of primary magnetic rare earths and critical minerals was discovered at its mine near
More news about: Ramaco Resources, Inc.
Mar 16, 2026, 08:01 ET Sentynl Therapeutics Enters into Agreement with PRG S&T to License Molecule for Hutchinson-Gilford Progeria Syndrome
Sentynl will acquire full rights to the investigational drug candidate, Progerinin (SLC-D011), adding to its commercial portfolio of rare and ultra-rare disease productsAHMEDABAD, India and SOLANA BEACH, Calif., March
More news about: Sentynl Therapeutics
Mar 16, 2026, 08:00 ET The State of America's Rare Earth Supply Chain in 2026 - OilPrice.com Market Commentary
anywhere in the Western world — a rare earth supply chain that doesn't touch China at any step. Japan figured out decades ago why that matters. Companies mentioned in this release include: REalloys Inc. (ALOY), MP Materials Corp. (NYSE: MP), USA Rare Earth (NASDAQ: USAR), Amprius
More news about: OilPrice.com
Mar 16, 2026, 08:00 ET Argo Biopharma Receives FDA Fast Track Designation for BW-20805, an Investigational siRNA Therapy for the Treatment of HAE
Review, if relevant criteria are met at the time of NDA filing.About Hereditary Angioedema (HAE)Hereditary angioedema (HAE) is a rare genetic condition that causes sudden and unpredictable swelling in different parts of the body. In severe cases, it can affect the throat and become
More news about: Argo Biopharmaceutical Co., Ltd
Mar 16, 2026, 08:00 ET Celltrion announces U.S. availability of AVTOZMA® (tocilizumab-anoh) subcutaneous (SC) formulation
in patients with known hypersensitivity.Demyelinating Disorders. The impact of tocilizumab on demyelinating disorders is unknown, but rare cases were reported; monitor symptoms and use caution with preexisting or recent disorders.Active Hepatic Disease and Hepatic Impairment. Treatment
More news about: Celltrion
Mar 16, 2026, 07:07 ET Early-Stage Founders and Students Across the Nation to Compete at Red Bull Basement 2026
easily attaches to pairs of glasses, providing assistance for individuals with visual impairments.Oberoi added that Red Bull Basement offered a rare moment of global community and inspiration: "I think competitions like Red Bull Basement are always such a celebration."How to EnterRed
More news about: Red Bull
Mar 16, 2026, 07:00 ET Keenova Therapeutics to Report Fourth-Quarter 2025 Financial Results on March 31, 2026
Therapeutics is a leading global developer and manufacturer of branded therapeutics that strives to help patients with rare or unaddressed conditions live happier and healthier lives.Keenova's rare disease capabilities underpin our diversified brands portfolio, which is focused across a wide range of therapeutic
More news about: Keenova Therapeutics
Mar 16, 2026, 07:00 ET BioLineRx to Report 2025 Annual Results on March 23, 2026
BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical development stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today announced that it will release its audited financial results for the year ended December 31, 2025 on Monday, March 23, 2026, before
More news about: BioLineRx Ltd.
Mar 16, 2026, 04:30 ET Lundbeck advances Parkinson's research with new Phase 1b data at AD/PD™ 2026
challenges. We develop transformative medicines targeting people for whom there are few or no treatments available, expanding into neuro-specialty and neuro-rare from our strong legacy within psychiatry and neurology.We are committed to fighting stigma and we act to improve health equity. We strive to
More news about: H. Lundbeck A/S
Mar 16, 2026, 04:27 ET Lundbeck advances Parkinson's research with new Phase 1b data at AD/PD™ 2026
challenges. We develop transformative medicines targeting people for whom there are few or no treatments available, expanding into neuro-specialty and neuro-rare from our strong legacy within psychiatry and neurology.We are committed to fighting stigma and we act to improve health equity. We strive to
More news about: H. Lundbeck A/S
Mar 16, 2026, 03:03 ET ROSE BYRNE WEARS DESERT DIAMONDS AT THE VANITY FAIR OSCAR PARTY
white diamonds in blackened white gold with a matte finish, to create visual tension and elevate their essence.""The act of creating something rare and precious with the right proportions and immaculate craft is the most charming task for a jeweler, and I'm grateful to bring to life the union of
More news about: A Diamond is Forever
Mar 15, 2026, 20:05 ET Shape the Future of Electrification: Registration Opens for CWIEME Shanghai 2026
Exhibitors—from materials innovators to winding technology leaders—will gain direct access to aerospace OEMs and top-tier robotics developers, offering a rare gateway into billion-dollar emerging markets.Introducing the C-Suite ClubFor the first time, CWIEME Shanghai will host an exclusive
More news about: CWIEME Shanghai
Mar 15, 2026, 19:50 ET ROSE BYRNE WEARS DESERT DIAMONDS ON THE RED CARPET AT THE 98TH ACADEMY AWARDS
Goldberg of William Goldberg said: "This ASHOKA diamond was Botswana sourced and created by our master cutters at William Goldberg. It is an extremely rare cognac diamond and we were proud to collaborate with Taffin to bring such an exceptional diamond to the world."Sally Morrison, Natural Diamonds
More news about: A Diamond is Forever
Mar 15, 2026, 10:00 ET Doctor-Approved Pure Health Supplements: PureHealth Research Sets a New Standard in Natural Wellness
developed under the guidance of a medical advisory board and backed by peer-reviewed science, offering consumers a level of trust that remains rare in the wellness industry.
More news about: PureHealth Research LLC
Mar 14, 2026, 19:30 ET Les VC et GC de Lord Ashcroft vont trouver un nouvel écrin au musée national de l'armée
l'armée et président de l'Association des VC et GC, a déclaré : "Cette collection rare et étendue couvre des siècles de service militaire, de sacrifices et de bravoure extraordinaires dans les forces armées : "Cette rare et vaste collection couvre des siècles de service militaire, de sacrifices et de
More news about: Lord Ashcroft
Mar 14, 2026, 19:30 ET Lord Ashcroft's VCs and GCs to have a new home at the National Army Museum
powerful part of the Army's story."Chris Finney, a Trustee of the National Army Museum and the Chair of the VC and GC Association, said: "This rare and expansive collection spans centuries of military service, sacrifice, and extraordinary bravery across the Armed Forces."We are privileged
More news about: Lord Ashcroft
Mar 14, 2026, 19:30 ET Lord Ashcroft's VCs and GCs to have a new home at the National Army Museum
powerful part of the Army's story."Chris Finney, a Trustee of the National Army Museum and the Chair of the VC and GC Association, said: "This rare and expansive collection spans centuries of military service, sacrifice, and extraordinary bravery across the Armed Forces."We are privileged
More news about: Lord Ashcroft
Mar 14, 2026, 19:30 ET Lord Ashcroft's VCs and GCs to have a new home at the National Army Museum
powerful part of the Army's story."Chris Finney, a Trustee of the National Army Museum and the Chair of the VC and GC Association, said: "This rare and expansive collection spans centuries of military service, sacrifice, and extraordinary bravery across the Armed Forces."We are privileged
More news about: Lord Ashcroft
Mar 14, 2026, 17:46 ET Soleno Therapeutics, Inc. (SLNO) Securities Fraud Class Action Lawsuit Filed; May 5, 2026, Lead Plaintiff Deadline
INC. CLASS ACTION LAWSUIT - COMPLAINT ALLEGATION SUMMARY:Soleno is a pharmaceutical company focused on developing therapies for rare diseases and is headquartered in Redwood City, California. At the time of the filing of the complaint, Soleno's only commercial product was diazoxide
More news about: Kessler Topaz Meltzer & Check, LLP
Mar 13, 2026, 22:16 ET Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Ultragenyx Pharmaceutical Inc. ("Ultragenyx" or the "Company") (NasdaqGS: RARE) of a class action securities lawsuit.
More news about: Kahn Swick & Foti, LLC
Mar 13, 2026, 17:15 ET Azitra Receives Notice of Non-Compliance from NYSE American and Makes NYSE American Section 610(b) Public Announcement
precision dermatology. The Company's lead program, ATR-12, uses an engineered strain of S. epidermidis designed to treat Netherton syndrome, a rare, chronic skin disease with no approved treatment options. Netherton syndrome may be fatal in infancy with those living beyond a year having profound
More news about: Azitra, Inc.
Mar 13, 2026, 16:30 ET PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
biopharmaceutical company dedicated to the discovery, development and commercialization of clinically differentiated medicines for children and adults living with rare disorders. PTC is advancing a robust and diversified pipeline of transformative medicines as part of its mission to provide access to best-in-class
More news about: PTC Therapeutics, Inc.